Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Chapter
  • Print publication year: 2005
  • Online publication date: August 2010

7 - Apoptosis in neurodegenerative diseases

from Part I - Basic aspects of neurodegeneration
Export citation
Summary

Introduction

Although reports on the morphological characteristics of apoptosis in neurodegenerative diseases remain controversial, accumulating evidence suggests that the molecular and biochemical pathways of apoptosis are involved in neuronal death of various neurodegenerative disorders and in related cellular and animal models. This includes stroke, head trauma, Huntington's (HD), Parkinson's (PD), Alzheimer's disease (AD and amyotrophic lateral sclerosis (ALS)). This evidence includes the activation of the mitogen activated protein (MAP) kinase pathway, the induction of Bax, prostate apoptosis response-4 (Par-4) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), evidence of aberrant activation of the cell cycle machinery, and the activation of caspases. Caspases are the mammalian cell-death-effector proteins. They may have an important role in acute and chronic neurodegenerative diseases. They execute cell death but may also be linked to the initiation of chronic neurodegenerative diseases. Peptide or protein inhibitors of caspases protect neurons in vitro or in animal models of neurological disorders. Although preclinical results are promising, clinical studies have not been performed because of the lack of synthetic caspase inhibitors that cross the blood–brain barrier. Such agents are a major focus in current programs of drug development and will hopefully become available soon. However, in some cell culture and animal models caspase inhibitors block cell death but may result in survival of a dysfunctional neuron. In contrast, therapeutic interference with the signaling phase of apoptosis, e.g. inhibition of the MAP kinase pathway, or the combination of caspase inhibitors with neurotrophins may provide morphological and functional protection.

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Neurodegenerative Diseases
  • Online ISBN: 9780511544873
  • Book DOI: https://doi.org/10.1017/CBO9780511544873
Please enter your name
Please enter a valid email address
Who would you like to send this to *

CAPTCHA *

Skip to the audio challenge
×
REFERENCES
Anderson, A. J., Su, J. H. & Cotman, C. W. (1996). DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci., 16, 1710–19
Andringa, G. & Cools, A. R. (2000). The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey. J. Neural Transm. Suppl., 215–25
Andringa, G., Oosten, R. V., Unger, W.et al. (2000). Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra. Eur. J. Neurosci., 12, 3033–43
Anglade, P., Vyas, S., Javoy-Agid, F.et al. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol., 12, 25–31
Banati, R. B., Daniel, S. E. & Blunt, S. B. (1998). Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord., 13, 221–7
Bilsland, J., Roy, S., Xanthoudakis, S.et al. (2002). Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci., 22, 2637–49
Bratton, S. B., Walker, G., Srinivasula, S. M.et al. (2001). Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J, 20, 998–1009
Cande, C., Cohen, I., Daugas, E.et al. (2002). Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie, 84, 215–22
Carlile, G. W., Chalmers-Redman, R. M., Tatton, N. A.et al. (2000). Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol. Pharmacol., 57, 2–12
Cassarino, D. S., Parks, J. K., Parker, W. D. Jr. & Bennett, J. P. Jr. (1999). The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Act., 1453, 49–62
Chen, M., Ona, V. O., Li, M.et al. (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med., 6, 797–801
Choi, W. S., Yoon, S. Y., Oh, T. H.et al. (1999). Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res., 57, 86–94
Clark, R. S., Kochanek, P. M., Chen, M.et al. (1999). Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J., 13, 813–21
Cornet, S., Spinnewyn, B., Delaflotte, S., et al. (2004). Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. Eur. J. Pharmacol., 505, 111–19
D'Souza, S. D., Bonetti, B., Balasingam, V.et al. (1996). Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med., 184, 2361–70
Deckwerth, T. L., Elliott, J. L., Knudson, C. M., Johnson, E. M., Snider, W. D. & Korsmeyer, S. J. (1996). Bax is required for neuronal death after trophic factor deprivation and during development. Neuron, 17, 401–11
Deveraux, Q. L. & Reed, J. C. (1999). IAP family proteins – suppressors of apoptosis. Genes Dev., 13, 239–52
Deveraux, Q. L., Roy, N., Stennicke, H. R.et al. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J., 17, 2215–23
Diguet, E., Fernagut, P. O., Wel, X.et al. (2004). Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur. J. Neurosci., 19, 3266–76
Dodel, R. C., Du, Y., Bales, K. R., Ling, Z. D., Carvey, P. M. & Paul, S. M. (1998). Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience, 86, 701–7
Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S. & Husar, W. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med., 184, 1513–18
Du, Y., Dodel, R. C., Bales, K. R., Jemmerson, R., Hamilton-Byrd, E. & Paul, S. M. (1997). Involvement of caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem., 69, 1382–8
Du, Y., Ma, Z., Lin, S.et al. (2001). Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci., USA, 98, 14669–74
Duan, W., Zhang, Z., Gash, D. M. & Mattson, M. P. (1999). Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Ann. Neurol., 46, 587–97
Eberhardt, O., Coelln, R. V., Kugler, S.et al. (2000). Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci., 20, 9126–34
Endres, M., Namura, S., Shimizu-Sasamata, M.et al. (1998). Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab., 18, 238–47
Fink, K., Zhu, J., Namura, S.et al. (1998). Prolonged therapuetic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood. Flow Metab., 18, 1071–6
Fink, K. B., Andrews, L. J., Butler, W. E.et al. (1999). Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience, 94, 1213–18
Fischer, U., Janicke, R. U. & Schulze-Osthoff, K. (2003). Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ., 10, 76–100
Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J. & Yuan, J. (1997). Inhibition of ICE slows ALS in mice [letter]. Nature, 388, 31
Fukuhara, Y., Takeshima, T., Kashiwaya, Y., Shimoda, K., Ishitani, R. & Nakashima, K. (2001). GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+ -induced apoptosis. NeuroReport, 12, 2049–52
Gerhardt, E., Kügler, S., Leist, M.et al. (2001). Cascade of caspase-activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis. Mol. Cell Neurosci., 17, 717–31
Gervais, F. G., Singaraja, R., Xanthoudakis, S.et al. (2002). Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol., 4, 95–105
Gervais, F. G., Xu, D., Robertson, G. S.et al. (1999). Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell, 97, 395–406
Ghadge, G. D., Lee, J. P., Bindokas, V. P.et al. (1997). Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci., 17, 8756–66
Goldberg, Y. P., Nicholson, D. W., Rasper, D. M.et al. (1996). Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet., 13, 442–9
Gomez, C., Reiriz, J., Pique, M., Gil, J., Ferrer, I. & Ambrosio, S. (2001). Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res., 63, 421–8
Guegan, C., Vila, M., Rosoklija, G., Hays, A. P. & Przedborski, S. (2001). Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci., 21, 6569–76
Guegan, C., Vila, M., Teissman, P.et al. (2002). Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell Neurosci., 20, 553–62
Guo, N., Krutzsch, H. C., Inman, J. K. & Roberts, D. D. (1997). Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res., 57, 1735–42
Hara, A., Yoshimi, N., Hirose, Y., Ino, N., Tanaka, T. & Mori, H. (1995). DNA fragmentation in granular cells of human cerebellum following global ischemia. Brain Res., 697, 247–50
Hara, H., Fink, K., Endres, M.et al. (1997a). Attenuation of transient focal cerebral ischemia injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab., 17, 370–5
Hara, H., Friedlander, R. M., Gagliardini, V.et al. (1997b). Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci., USA, 94, 2007–12
Hartmann, A., Hunot, S., Michel, P. P.et al. (2000). Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci., USA, 97, 2875–80
Hartmann, A., Michel, P. P., Troadec, J. D.et al. (2001a). Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?J. Neurochem., 76, 1785–93
Hartmann, A., Troadec, J. D., Hunot, S.et al. (2001b). Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci., 21, 2247–55
Hegde, R., Srinivasula, S. M., Zhang, Z.et al. (2002). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432–8
Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature, 407, 770–6
Himi, T., Ishizaki, Y. & Murota, S. (1998). A caspase inhibitor blocks ischaemia-induced delayed neuronal death in the gerbil. Eur. J. Neurosci., 10, 777–81
Hisahara, S., Araki, T., Sugiyama, F.et al. (2000). Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J., 19, 341–8
Ishitani, R. & Chuang, D. M. (1996). Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl Acad. Sci., USA, 93, 9937–41
Ishitani, R., Kimura, M., Sunaga, K., Katsube, N., Tanaka, M. & Chuang, D. M. (1996a). An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J. Pharmacol. Exp. Ther., 278, 447–54
Ishitani, R., Sunaga, K., Hirano, A., Saunders, P., Katsube, N. & Chuang, D. M. (1996b). Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem., 66, 928–35
Ishitani, R., Sunaga, K., Tanaka, M., Aishita, H. & Chuang, D. M. (1997). Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol. Pharmacol., 51, 542–50
Jones, J. M., Datla, P., Srinivasula, S. M.et al. (2003). Loss of Ori mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721–7
Kang, S. J., Wang, S., Hara, H . et al. (2000). Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol., 149, 613–22
Kermer, P., Klöcker, N., Labes, M. & Bähr, M. (1998). Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J. Neurosci., 15, 4656–62
Klein, J. A., Longo-Guess, C. M., Rossmann, M. P.et al. (2002). The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature, 419, 367–74
Klevenyi, P., Andreassen, O., Ferrante, R. J., Schleicher, J. R., Friedlander, R. M.Jr. & Beal, M. F. (1999). Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. NeuroReport, 10, 635–8
Kluck, R. M., Esposti, M. D., Perkins, G.et al. (1999). The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J. Cell Biol., 147, 809–22
Kosel, S., Egensperger, R., Voneitzen, U., Mehraein, P. & Graeber, M. B. (1997). On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol., 93, 105–8
Kostic, V., Jackson-Lewis, V., Bilbao, F., Dubois-Dauphin, M. & Przedborski, S. (1997). Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science, 277, 559–62
Kragten, E., Lalande, I., Zimmermann, K.et al. (1998). Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(–)-deprenyl. J. Biol. Chem., 273, 5821–8
Krajewska, M., Wang, H.-G., Krajewski, S.et al. (1997). Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res., 57, 1605–13
Kroemer, G. (1997). Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ., 4, 443–56
Kugler, S., Straten, G., Kreppel, F., Isenmann, S., Liston, P. & Bahr, M. (2000). The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ., 7, 815–24
Leist, M. & Jaattela, M. (2001). Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol., 2, 589–98
Li, P., Nijhawan, D., Budihardjo, I.et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479–89
Li, M., Ona, V. O., Guegan, C.et al. (2000). Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288, 335–9
Lipton, S. A. & Bossy-Wetzel, E. (2002). Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell, 111, 147–50
Loddick, S. A. & Rothwell, N. J. (1996). Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab., 16, 932–40
Loddick, S. A., MacKenzie, A. & Rothwell, N. J. (1996). An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport, 7, 1465–8
Ma, J., Endres, M. & Moskowitz, M. A. (1998). Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischemia in mice. Br. J. Pharmacol., 124, 756–62
MacManus, J. P., Buchan, A. M., Hill, I. E., Rasquinha, I. & Preston, E. (1993). Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett., 164, 89–92
MacManus, J. P., Hill, I. E., Huang, Z. G., Rasquinha, I., Xue, D. & Buchan, A. M. (1994). DNA damage consistent with apoptosis in transient focal ischaemic neocortex. NeuroReport, 5, 493–6
Martin, L. J. (1999). Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol., 58, 459–71
Martinou, J. C. & Green, D. R. (2001). Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol., 2, 63–7
Matsushita, K., Wu, Y., Qiu, J.et al. (2000). Fas receptor and neuronal cell death after spinal cord ischemia. J. Neurosci., 20, 6879–87
Mattson, M. P. (2000). Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol., 1, 120–9
McGeer, P. L., Itagaki, S., Akiyama, H. & McGeer, E. G. (1988). Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol., 24, 574–6
Mochizuki, H., Goto, K., Mori, H. & Mizuno, Y. (1996). Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci., 137, 120–3
Mochizuki, H., Hayakawa, H., Migita, M.et al. (2001). An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc. Natl Acad. Sci., USA, 98, 10918–23
Morita-Fujimura, Y., Fujimura, M., Kawase, M., Murakami, K., Kim, G. W. & Chan, P. H. (1999). Inhibition of interleukin-1 beta converting enzyme family proteases (caspases) reduces cold injury-induced brain trauma and DNA fragmentation in mice. J. Cereb. Blood Flow Metab., 19, 634–42
Namura, S., Zhu, J., Fink, K.et al. (1998). Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci., 18, 3659–68
Nguyen, M. D., Julien, J. P. & Rivest, S. (2001). Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol., 50, 630–9
Nicholson, D. W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ., 6, 1028–42
Okada, H., Suh, W. K., Jin, J.et al. (2002). Generation and characterization of Smac/DIABLO-deficient mice. Mol. Cell Biol., 22, 3509–17
Ona, V. O., Li, M., Vonsattel, J. P.et al. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature, 399, 263–7
Ozawa, K., Suchanek, G., Breitschopf, H.et al. (1994). Patterns of oligodendroglia pathology in multiple sclerosis. Brain, 117, 1311–22
Portera-Cailliau, C., Hedreen, J. C., Price, D. L. & Koliatsos, V. E. (1995). Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci., 15, 3775–87
Putcha, G. V., Moulder, K. L., Golden, J. P.et al. (2001). Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron, 29, 615–28
Putcha, G. V., Harris, C. A., Moulder, K. L., Easton, R. M., Thompson, C. B. & Johnson, E. M. Jr. (2002). Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J. Cell Biol., 157, 441–53
Rano, T. A., Timkey, T., Peterson, E. P.et al. (1997). A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). Chem. Biol., 4, 149–55
Raoul, C., Henderson, C. E. & Pettmann, B. (1999). Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol., 147, 1049–62
Raoul, C., Estevez, A. G., Nishimune, H.et al. (2002). Motoneuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations. Neuron, 35, 1067–83
Rathke-Hartlieb, S., Schlomann, U., Heirnann, P., Meisler, M. H., Jackusch, H. & Bartsch, J. W. (2002). Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2. Exp. Neurol., 175, 87–97
Ravagnan, L., Gurbuxani, S., Susin, S. A.et al. (2001). Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol., 3, 839–43
Robertson, G. S., Crocker, S. J., Nicholson, D. W. & Schulz, J. B. (2000). Neuroprotection by the inhibition of apoptosis. Brain Pathol, 10, 283–92
Saito, M., Korsmeyer, S. J. & Schlesinger, P. H. (2000). BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell Biol., 2, 553–5
Sanchez, I., Xu, C. J., Juo, P., Kakizaka, A., Blenis, J. & Yuan, J. (1999). Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron, 22, 623–33
Sanna, M. G., Duckett, C. S., Richter, B. W., Thompson, C. B. & Ulevitch, R. J. (1998). Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl Acad. Sci., USA, 95, 6015–20
Sanna, M. G., da Silva Correia, J., Ducrey, O.et al. (2002). IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol. Cell Biol., 22, 1754–66
Saporito, M. S., Brown, E. M., Miller, M. S. & Carswell, S. (1999). CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther., 288, 421–7
Saporito, M. S., Thomas, B. A. & Scott, R. W. (2000). MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem., 75, 1200–8
Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M. E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55–66
Saunders, P. A., Chen, R. W. & Chuang, D. M. (1999). Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J. Neurochem., 72, 925–32
Schulz, J. B., Weller, M., Matthews, R. T.et al. (1998). Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ., 5, 847–57
Shashidharan, P., Chalmers-Redman, R. M., Carlile, G. W.et al. (1999). Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. NeuroReport, 10, 1149–53
Shimizu, S., Narita, M. & Tsujimoto, Y. (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483–7
Simons, M., Beinroth, S., Gleichmann, M.et al. (1999). Adenovirus-mediated gene transfer of IAPs delays apoptosis of cerebellar granule neurons. J. Neurochem., 72, 292–301
Slee, E. A., Harte, M. T., Kluck, R. M.et al. (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol., 144, 281–92
Somia, N. V., Schmitt, M. J., Vetter, D. E., Antwerp, D., Heinemann, S. F. & Verma, I. M. (1999). LFG: An anti-apoptotic gene that provides protection from fas-mediated cell death. Proc. Natl Acad. Sci., USA, 96, 12667–72
Springer, J. E., Azbill, R. D. & Knapp, P. E. (1999). Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med., 5, 943–6
Srinivasula, S. M., Hegde, R., Saleh, A.et al. (2001). A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature, 410, 112–16
Stennicke, H. R., Deveraux, Q. L., Humke, E. W., Reed, J. C., Dixit, V. M. (1999). Caspase-9 can be activated without proteolytic processing. J. Biol. Chem., 274, 8359–62
Thornberry, N. A., Rano, T. A., Peterson, E. P.et al. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 272, 17907–11
Tompkins, M., Basgall, E., Zamrini, E. & Hill, W. (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol., 150, 119–31
Loo, G., Saelens, X., Gurp, M., MacFarlane, M., Martin, S. J. & Vandenabeele, P. (2002). The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ., 9, 1031–42
Velier, J. J., Ellison, J. A., Kikly, K. K., Spera, P. A., Barone, F. C. & Feuerstein, G. Z. (1999). Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J. Neurosci., 19, 5932–41
Vila, M., Jackson-Lewis, V. V., Vukosavic, S.et al. (2001). Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl Acad. Sci., USA, 98, 2837–42
Viswanath, V., Wu, Z., Fonck, C., Wei, Q., Boonplueang, R. & Andersen, J. K. (2000). Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc. Natl Acad. Sci., USA, 97, 2270–5
Viswanath, V., Wu, Y., Boonplueang, R.et al. (2001). Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci., 21, 9519–28
Coelln, R., Kugler, S., Bahr, M., Weller, M., Dichgans, J. & Schulz, J. B. (2001). Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem., 77, 263–73
Vukosavic, S., Dubois-Dauphin, M., Romero, N. & Przedborski, S. (1999). Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 73, 2460–8
Vukosavic, S., Stefanis, L., Jackson-Lewis, V.et al. (2000). Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci., 20, 9119–25
Waldmeier, P. C., Spooren, W. P. & Hengerer, B. (2000). CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease. Naunyn Schmiedebergs Arch. Pharmacol., 362, 526–37
Wellington, C. L., Ellerby, L. M., Hackam, A. S.et al. (1998). Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem., 273, 9158–67
Wellington, C. L., Ellerby, L. M., Gutekunst, C. A.et al. (2002). Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci., 22, 7862–72
Whitfield, J., Neame, S. J., Paquet, L., Bernard, O. & Ham, J. (2001). Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron, 29, 629–43
Wu, D. C., Jackson-Lewis, V., Vila, M.et al. (2002). Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci., 22, 1763–71
Wüllner, U., Kornhuber, J., Weller, M.et al. (1999). Cell death and apoptosis regulating proteins in Parkinson's disease – a cautionary note. Acta Neuropathol., 97, 408–12
Xia, X. G., Harding, T., Weller, M., Bieneman, A., Uney, J. B. & Schulz, J. B. (2001). Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci., USA, 98, 10433–8
Xu, D. G., Crocker, S. J., Doucet, J.-P.et al. (1997). Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat. Med., 3, 997–1004
Xu, D., Bureau, Y., McIntyre, D. C.et al. (1999). Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci., 19, 5026–33
Yakovlev, A. G., Knoblach, S. M., Fan, L., Fox, G. B., Goodnight, R. & Faden, A. I. (1997). Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci., 17, 7415–24
Yang, L., Matthews, R. T., Schulz, J. B.et al. (1998). MPTP neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci., 18, 8145–52
Yang, L., Sugama, S., Chirichigno, J. W.et al. (2003). Minocycline enhances MPTP toxicity to dopaminergic neurons, J. Neurosci. Res., 74, 278–85
Zhu, S., Stavrovskaya, I. G., Drozda, M.et al. (2002). Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417, 74–8
Cancel
Confirm
×